Suppr超能文献

尼日利亚中北部洛科贾医疗服务提供者对青蒿素联合疗法的偏好

Preference for Artemisinin-based combination therapy among healthcare providers, Lokoja, North-Central Nigeria.

作者信息

Welle Sylvanus C, Ajumobi Olufemi, Dairo Magbagbeola, Balogun Muhammad, Adewuyi Peter, Adedokun Babatunde, Nguku Patrick, Gidado Saheed, Ajayi IkeOluwapo

机构信息

1Division of Health Promotion, Department of Family Health, Federal Ministry of Health, Abuja, Nigeria.

Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria.

出版信息

Glob Health Res Policy. 2019 Jan 19;4:1. doi: 10.1186/s41256-018-0092-9. eCollection 2019.

Abstract

BACKGROUND

In Nigeria, Artemisinin-based Combination Therapy (ACT) is the recommended first line antimalarial medicine for uncomplicated malaria. However, health care providers still continue the use of less efficacious medicines such as Sulphadoxine-pyrimethamine and chloroquine. We therefore determined preference for ACT (PFA) and factors associated with PFA among healthcare providers (HCP) in Lokoja, North-Central Nigeria as well as assessed healthcare providers' knowledge of malaria case management.

METHODS

We conducted a cross-sectional study among physicians, nurses, pharmacists, community health officers (CHOs), community health extension workers (CHEWs) and, patent and proprietary medicine vendors (PPMVs). Interviewer-administered questionnaires were administered to collect data on respondents' characteristics, previously received malaria case management training and knowledge of malaria treatment. Knowledge scores ≥3 were categorised as good, maximum obtainable being 5.

RESULTS

Of the 404 respondents, 214 (53.0%) were males. Overall, 219 (54.2%) respondents who received malaria case management training  included PPMVs: 79 (65.8%), CHEWs: 25 (64.1%), CHOs: 5 (55.6%), nurses: 72 (48.7%), physicians: 35 (47.3%) and pharmacists: 3 (23.1%). Overall, 202 (50.0%) providers including physicians: 69 (93.2%), CHO: 8 (88.9%), CHEWs: 33 (84.6%), pharmacists: 8 (61.5%), nurses: 64 (43.2%) and PPMVs: 20 (16.5%), had good knowledge of malaria treatment guidelines. Overall, preference for ACT among healthcare providers was 39.6%. Physicians: 50 (67.6%), pharmacists: 7 (59.3%) CHOs: 5 (55.6%), CHEWS: 16 (41.0%), nurses: 56 (37.8%) and PPMV: 24 (19.8%) had PFA. Receiving malaria case management training (adjusted odds ratio [aOR]) = 2.3; CI = 1.4 - 3.7) and having good knowledge of malaria treatment (aOR = 4.0; CI = 2.4 - 6.7) were associated with PFA.

CONCLUSIONS

Overall preference for ACT use was low among health care providers in this study. Preference for ACTs and proportion of health workers with good knowledge of malaria case management were even lower among PPMVs who had highest proportion of those who received malaria case management training. We recommend evaluation of current training quality, enhanced targeted training, follow-up supportive supervision of PPMVs and behavior change communication on ACT use.

摘要

背景

在尼日利亚,以青蒿素为基础的联合疗法(ACT)是治疗非复杂性疟疾的推荐一线抗疟药物。然而,医疗保健提供者仍在继续使用疗效较差的药物,如磺胺多辛-乙胺嘧啶和氯喹。因此,我们确定了尼日利亚中北部洛科贾医疗保健提供者(HCP)对ACT的偏好(PFA)以及与PFA相关的因素,并评估了医疗保健提供者对疟疾病例管理的知识。

方法

我们对医生、护士、药剂师、社区卫生官员(CHO)、社区卫生推广工作者(CHEW)以及专利和成药供应商(PPMV)进行了一项横断面研究。通过访谈者实施的问卷收集有关受访者特征、先前接受的疟疾病例管理培训以及疟疾治疗知识的数据。知识得分≥3被归类为良好,最高可得分为5分。

结果

在404名受访者中,214名(53.0%)为男性。总体而言,219名(54.2%)接受过疟疾病例管理培训的受访者包括PPMV:79名(65.8%)、CHEW:25名(64.1%)、CHO:5名(55.6%)、护士:72名(48.7%)、医生:35名(47.3%)和药剂师:3名(23.1%)。总体而言,202名(50.0%)提供者包括医生:69名(93.2%)、CHO:8名(88.9%)、CHEW:33名(84.6%)、药剂师:8名(61.5%)、护士:64名(43.2%)和PPMV:20名(16.5%),对疟疾治疗指南有良好的了解。总体而言,医疗保健提供者对ACT的偏好为39.6%。医生:50名(67.6%)、药剂师:7名(59.3%)、CHO:5名(55.6%)、CHEW:16名(41.0%)、护士:56名(37.8%)和PPMV:24名(19.8%)有PFA。接受疟疾病例管理培训(调整后的优势比[aOR])=2.3;CI=1.4 - 3.7)以及对疟疾治疗有良好的了解(aOR=4.0;CI=2.4 - 6.7)与PFA相关。

结论

在本研究中,医疗保健提供者对使用ACT的总体偏好较低。在接受疟疾病例管理培训比例最高的PPMV中,对ACT的偏好以及对疟疾病例管理有良好了解的卫生工作者比例甚至更低。我们建议评估当前的培训质量,加强有针对性的培训,对PPMV进行后续支持性监督,并就ACT的使用开展行为改变宣传。

相似文献

1
Preference for Artemisinin-based combination therapy among healthcare providers, Lokoja, North-Central Nigeria.
Glob Health Res Policy. 2019 Jan 19;4:1. doi: 10.1186/s41256-018-0092-9. eCollection 2019.

本文引用的文献

2
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Parasitol Res. 2017 Feb;116(2):781-788. doi: 10.1007/s00436-016-5353-2. Epub 2016 Dec 27.
3
Adherence to malaria diagnosis and treatment guidelines among healthcare workers in Ogun State, Nigeria.
BMC Public Health. 2016 Aug 19;16(1):828. doi: 10.1186/s12889-016-3495-x.
4
The role of drug vendors in improving basic health-care services in Nigeria.
Bull World Health Organ. 2016 Apr 1;94(4):267-75. doi: 10.2471/BLT.15.154666. Epub 2016 Feb 3.
6
A systematic review of the role of proprietary and patent medicine vendors in healthcare provision in Nigeria.
PLoS One. 2015 Jan 28;10(1):e0117165. doi: 10.1371/journal.pone.0117165. eCollection 2015.
7
Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.
Am J Trop Med Hyg. 2014 Nov;91(5):925-935. doi: 10.4269/ajtmh.13-0248. Epub 2014 Sep 22.
8
Increasing use of artemisinin-based combination therapy for treatment of malaria infection in Nigerian hospitals.
Pharm Pract (Granada). 2010 Oct;8(4):243-9. doi: 10.4321/s1886-36552010000400007. Epub 2010 Mar 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验